Virtual reality headsets could ease ICU trauma for lung transplant patients

NCT ID NCT05125406

Completed Symptom relief Sponsor: Assistance Publique Hopitaux De Marseille Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether using virtual reality (VR) exposure therapy could prevent anxiety, depression, and PTSD in people recovering from a lung transplant in the ICU. 62 adults on the lung transplant waiting list participated. They used a VR headset to gradually get used to stressful ICU situations like alarms, aiming to reduce psychological distress.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Virtual reality exposure therapy
What this could lead to: If it works, this could offer a drug-free way to prevent anxiety and PTSD after lung transplant.
What could go wrong: This is a small, early study with only 62 participants. The results may not apply to everyone, and the virtual reality scenarios might not reduce anxiety for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION, ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression mixed anxiety and depressive disorder post-traumatic stress disorder anxiety disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEPRESSION, ANXIETY PTSD TRANSPLANTATION, LUNG

Contacts and locations

Locations

Assistance Publique Des Hôpitaux de Marseille

Marseille, 13354, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.